Richard Chau

A recent study published in Nature in late March revealed that modulating the composition of hematopoietic stem cells in elderly mice helped revitalize their immune systems and improve their ability to fend off viral infections.

Researchers from the University of Hong Kong Li Ka Shing Faculty of Medicine (HKUMed) and Faculty of Engineering have made significant strides in understanding the impact of SARS-CoV-2 mutations on disease severity. Their innovative screening platform offers a speed improvement of up to 39 times compared to traditional methods.

Published in the April 12 issue of Science Advances, engineers from Rice University have recently developed the smallest implantable brain stimulator ever demonstrated in a human patient, marking a significant advancement in the treatment of depression and various neurological disorders.

Scientists at the University of California, Riverside (UC Riverside) have recently unveiled a groundbreaking RNA-based vaccine strategy that could revolutionize vaccination efforts against a myriad of viruses.

Published in Nature Metabolism, UC Berkeley researchers recently presented new evidence that lactate serves as a vital component in managing carbohydrate metabolism, debunking the myth that lactate formation signals oxygen deprivation in muscles.

On May 21, Eli Lilly and Company announced a $1.16 billion, multi-target drug discovery collaboration with Aktis Oncology, a biotech company specializing in novel targeted radiopharmaceuticals for solid tumors.

Following the success of previous years, Taiwan's Biotechnology and Pharmaceutical Industries Promotion Office (BPIPO), MOEA will participate in BIO 2024 by organizing a Taiwan delegation with over 60 delegates and accompanying organizations.

On July 3, the Science and Technology Law Institute (STLI) organized a webinar on global regulatory trends in regenerative medicine. Dr. Shin Kawamata, CEO of Cyto-Facto, a Japanese cell and gene therapy CDMO company, and Dr. Christopher Tsai, Chairman of the BIONET Group, were invited as speakers for the event.

Webinar Series on International Regulatory Affairs: The major regulatory issues and challenges related to nucleic acid drugs.

STLI organized the webinar themed “Pharmaceutical Innovations with AI/ML and Digital Technology” on August 21 in cooperation with GeneOnline.